| Date Filed | Type | Description |
| 08/15/2023 |
4
| Behbahani Ali (10% Owner) has filed a Form 4 on Bright Health Group Inc.|
Txns:
| Bought 828,395 warrants
@ $0.01, valued at
$8.3k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 1,000,000 shares
@ $5, valued at
$5M
|
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 5,655 shares
@ $2.1, valued at
$11.9k
|
|
| 06/16/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Granted 11,459 options to buy
@ $37.94, valued at
$434.8k
|
|
| 06/09/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 13,000 options to buy
@ $62.59, valued at
$813.7k
|
|
| 06/09/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 22,500 options to buy
@ $4.86, valued at
$109.4k
|
|
| 06/07/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on CVRx, Inc.|
Txns:
| Granted 12,012 options to buy
@ $12.33, valued at
$148.1k
|
|
| 06/05/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Acquired 113 shares
@ $0
Acquired 28 shares
@ $0 |
|
| 05/17/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Disposed/sold 10,066 shares
@ $0
Disposed/sold 3,573 shares
@ $0
Disposed/sold 5,359 options to buy
@ $3.63, valued at
$19.5k
Disposed/sold 5,199 options to buy
@ $17.74, valued at
$92.2k
|
|
| 12/22/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Acquired 57 shares
@ $0
Acquired 226 shares
@ $0 |
|
| 12/19/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 7,917 shares
@ $1.5, valued at
$11.9k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 4,532 shares
@ $2.62, valued at
$11.9k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 5,850 shares
@ $2.03, valued at
$11.9k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.14, valued at
$32.1k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14.95, valued at
$239.2k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Granted 3,573 shares
@ $0
Granted 5,359 options to buy
@ $3.63, valued at
$19.5k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2022 |
4
| Behbahani Ali (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 2,631,578 shares
@ $1.9, valued at
$5M
Bought 948,948 shares
@ $1.9, valued at
$1.8M
Bought 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
| 03/18/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 4,346 shares
@ $3.02, valued at
$13.1k
|
|
| 02/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2022 |
4
| Behbahani Ali (10% Owner) has filed a Form 4 on Bright Health Group Inc.|
Txns:
| Bought 75,000 options to buy
@ $1000, valued at
$75M
Bought 125,000 options to buy
@ $1000, valued at
$125M
|
|
| 12/27/2021 |
4
| Behbahani Ali (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/17/2021 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 2,472 shares
@ $5.31, valued at
$13.1k
|
|
|